ERG expression can predict the outcome of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer

Küronya Zsófia and Sükösd Farkas and Varga Linda and Bíró Krisztina and Gyergyay Fruzsina and Géczi Lajos and Nagyiványi Krisztián András and Jorgo Kliton and Szarvas Tibor and Kovács Ágnes and Laczkó Ibolya and Varga Zoltán and Pósfai Boglárka and Pepó Judit and Maráz Anikó: ERG expression can predict the outcome of docetaxel combined with androgen deprivation therapy in metastatic hormone-sensitive prostate cancer.
UROLOGIC ONCOLOGY: SEMINARS AND ORIGINAL INVESTIGATIONS, 37 (4). 289.e1-289.e9. ISSN 1078-1439 (2019)

[thumbnail of 30476714.pdf] Text
30476714.pdf - Published Version
Restricted access: Registered users only

Download (1MB) | Request a copy
Item Type: Article
Journal or Publication Title: UROLOGIC ONCOLOGY: SEMINARS AND ORIGINAL INVESTIGATIONS
Date: 2019
Volume: 37
Number: 4
Page Range: 289.e1-289.e9
ISSN: 1078-1439
Faculty/Unit: Faculty of Medicine
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 30476714
DOI azonosító: https://doi.org/10.1016/j.urolonc.2018.12.007
Date Deposited: 2019. Dec. 20. 11:06
Last Modified: 2019. Dec. 20. 11:06
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/17760
Web of Science® Times Cited: 3 View citing articles in Web of Science®

Actions (login required)

View Item View Item